Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 6/20 | 0.62 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.62 |
| ▸ | NTRK3 | Q16288 | 2/20 | 0.62 |
| ▸ | NTRK2 | Q16620 | 2/20 | 0.62 |
| ▸ | FCER2 | P06734 | 1/20 | 0.62 |
| ▸ | SRC | P12931 | 2/20 | 0.55 |
| ▸ | CDK2 | P24941 | 2/20 | 0.53 |
| ▸ | RET | P07949 | 2/20 | 0.52 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.52 |
| ▸ | KDR | P35968 | 1/20 | 0.52 |
| ▸ | CSNK1D | P48730 | 3/20 | 0.47 |
| ▸ | CSNK1A1 | P48729 | 2/20 | 0.47 |
| ▸ | CSNK1E | P49674 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | GMNN | O75496 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5361448 | 0.91 | SYK (0.65) | SYKNTRK1NTRK3NTRK2FCER2 | |
| SCHEMBL7132123 | 0.90 | SYK (0.62) | SYKNTRK1NTRK3NTRK2FCER2 | |
| SCHEMBL5370052 | 0.88 | CSNK1D (0.64) | SYKNTRK1NTRK3NTRK2FCER2 | |
| SCHEMBL5367766 | 0.87 | GSK3B (0.61) | SYKNTRK1NTRK3NTRK2FCER2 | |
| SCHEMBL5357858 | 0.87 | LRRK2 (0.65) | SYKNTRK1NTRK3NTRK2FCER2 | |
| SCHEMBL7138006 | 0.86 | SRC (0.57) | SYKNTRK1NTRK3NTRK2FCER2 | |
| SCHEMBL7131357 | 0.86 | SYK (0.57) | SYKNTRK1NTRK3NTRK2FCER2 | |
| SCHEMBL5359504 | 0.84 | PSEN1 (0.56) | SYKNTRK1NTRK3NTRK2FCER2 | |
| SCHEMBL5373774 | 0.84 | SYK (0.53) | SYKNTRK1NTRK3NTRK2FCER2 | |
| SCHEMBL5368923 | 0.84 | ERBB2 (0.59) | SYKNTRK1NTRK3NTRK2FCER2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7202265-B2 | Indolinone combinatorial libraries and related products and methods for the treatment of disease | SUGEN, INC. (US) | 2007-04-10 | — | — | US | disclosed |
| US-20050197382-A1 | Indolinone combinatorial libraries and related products and methods for the treatment of disease | SUGEN, INC. | 2005-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050197382-A1 | Indolinone combinatorial libraries and related products and methods for the treatment of disease | FRK, PTK2, DSTYK | SYK 54/4885NTRK1 223/4885NTRK3 358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.